|Amgen Inc -- USA Stock|| |
USD 186.11 0.18 0.10%
Mr. Frank C. Herringer is an Independent Director of Amgen Inc. Frank C. Herringer was a director of the Board of Transamerica Corporationrationration, a financial services company, since 1986, serving as Chairman of the board of directors from 1995 to December 2015. Mr. Herringer was an executive with Transamerica for 20 years, including its Chief Executive Officer from 1991 until its acquisition by Aegon N.V., a life insurance, pensions and asset management company, in 1999, subsequently serving on Aegons Executive Board for one year. Mr. Herringer was a director of Aegon U.S. Holding Corporationrationration from 1999 until its merger into Transamerica Corporationrationration in December 2015.
Age: 73 Director Since 2004
805 447-1010 www.amgen.com
Herringer received an undergraduate degree and master?s degree in business administration from Dartmouth College.
Frank Herringer Latest Insider Activity
The company has return on total asset (ROA)
of 8.27 %
which means that it generated profit of $8.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE)
of 26.43 %
meaning that it created $26.43 on every $100 dollars invested by stockholders.
The company currently holds 35.06 B in liabilities with Debt to Equity (D/E) ratio of 110.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 6.08 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 17,900 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.